{
    "title": "Immunomedics drug Trodelvy extends survival in breast cancer patients",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8750677/Immunomedics-drug-Trodelvy-extends-survival-breast-cancer-patients.html",
    "date": "2020-09-19",
    "keywords": [
        "cancer",
        "drug",
        "approval",
        "trodelvy",
        "company",
        "breast",
        "fda",
        "maddipatla",
        "trial",
        "saturday",
        "use",
        "confirmatory",
        "oncology",
        "april",
        "time",
        "form",
        "food",
        "administration",
        "morris",
        "drugmaker",
        "gilead",
        "deal",
        "sept",
        "mtnbc",
        "verification",
        "benefit",
        "risk",
        "death",
        "percent",
        "survival",
        "latestage",
        "chemotherapy",
        "quarter",
        "realtime",
        "review",
        "rtor",
        "process",
        "agency",
        "data",
        "marketing",
        "application",
        "conjugate",
        "protein",
        "trop2",
        "surface",
        "nonsmall",
        "cell",
        "lung",
        "label",
        "fdas",
        "harshest",
        "diarrhea",
        "count",
        "type",
        "blood",
        "society",
        "meeting",
        "reporting",
        "manojna",
        "bengaluru",
        "editing"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}